pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Sep 8·1 min read
save

Oura files for IPO after reporting $1.2 billion in earnings

Sep 8, 2026·read at STAT ↗DealPositive

Oura, the maker of popular health tracking rings, announced it will go public through an initial public offering.

The company disclosed that it generated $1.2 billion in earnings during its most recent fiscal year, indicating strong financial performance.

The filing comes as the broader health tech sector sees increased investor interest, while regulatory bodies such as the FDA continue to see turnover among digital health leaders.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Oura files to goes public, reported $1.2B in earnings”

read at STAT ↗
406 words · retrieved Sep 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ASTRAZENECANOVARTISNOVONovo Nordisk Inc
topics
Cardiology2Psychiatry & CNS2Breast CancerOncologyPulmonology

related stories

  • Sep 14STAT+: GSK touts lung cancer data from two drugsSTAT
  • Sep 8STAT+: FDA approves AstraZeneca breast cancer drugSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 20h agoEyepoint, Enlivex enact heavy layoffsBioSpace
  • Sep 9STAT+: Pharmalittle: We’re reading about an AstraZeneca COPD win, the FDA filling key jobs, and moreSTAT